These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23031346)

  • 1. The precarious path to diagnostic accuracy: the Ontario hormone receptor guideline.
    Hughes-Davies L
    Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):682-3. PubMed ID: 23031346
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer care Ontario guideline recommendations for hormone receptor testing in breast cancer.
    Nofech-Mozes S; Vella ET; Dhesy-Thind S; Hanna WM
    Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):684-96. PubMed ID: 22608362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing concepts of hormone receptor-positive advanced breast cancer therapy.
    Chlebowski RT
    Clin Breast Cancer; 2013 Jun; 13(3):159-66. PubMed ID: 23228361
    [No Abstract]   [Full Text] [Related]  

  • 4. Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist?
    De Maeyer L; Van Limbergen E; De Nys K; Moerman P; Pochet N; Hendrickx W; Wildiers H; Paridaens R; Smeets A; Christiaens MR; Vergote I; Leunen K; Amant F; Neven P
    J Clin Oncol; 2008 Jan; 26(2):335-6; author reply 336-8. PubMed ID: 18182677
    [No Abstract]   [Full Text] [Related]  

  • 5. Problems and solutions in the evaluation of hormone receptors in breast cancer.
    Allred DC
    J Clin Oncol; 2008 May; 26(15):2433-5. PubMed ID: 18487563
    [No Abstract]   [Full Text] [Related]  

  • 6. [Detection and treatment of ductal carcinoma of the breast].
    Semiglazov VV; Tabagua TT; Matsko DE
    Vopr Onkol; 2011; 57(6):699-701. PubMed ID: 22416383
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical aspects of steroid receptor assays.
    Leake RE
    Med Lab Sci; 1984 Jul; 41(3):257-61. PubMed ID: 6482693
    [No Abstract]   [Full Text] [Related]  

  • 8. [Endocrine therapy for postmenopausal breast cancer (role of cycline D1)].
    Manikhas AG; Skvortsov VA; Manikhas GM; Raskin GA; Oganesian AS; Shemerovskiĭ AK
    Vopr Onkol; 2011; 57(5):641-4. PubMed ID: 22238936
    [No Abstract]   [Full Text] [Related]  

  • 9. HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells.
    Pietras RJ; Arboleda J; Reese DM; Wongvipat N; Pegram MD; Ramos L; Gorman CM; Parker MG; Sliwkowski MX; Slamon DJ
    Oncogene; 1995 Jun; 10(12):2435-46. PubMed ID: 7784095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen and progesterone receptor structure and action in breast cancer cells.
    Bettuzzi S; Robinson A; Fuchs-Young R; Greene GL
    Cancer Treat Res; 1992; 61():301-15. PubMed ID: 1360239
    [No Abstract]   [Full Text] [Related]  

  • 11. Hormone receptor expression in breast cancer: postanalytical issues.
    Lee M; Lee CS; Tan PH
    J Clin Pathol; 2013 Jun; 66(6):478-84. PubMed ID: 23526546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Microviscosity of erythrocyte membranes in breast cancer patients: connection with the receptor phenotype of the tumor].
    Tsyrlina EV; Kriukova OG; Poroshina TE; Tyrkevich EA; Barash NIu; Mullakhmetova ZI; Semiglazov VF; Bershteĭn LM
    Vopr Onkol; 2014; 60(4):504-9. PubMed ID: 25552073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hormone treatment of breast cancer].
    Gröhn P
    Duodecim; 1991; 107(8):603-10. PubMed ID: 1364913
    [No Abstract]   [Full Text] [Related]  

  • 14. [Zosteriform eruption resistant to acyclovir].
    Orgaz-Molina J; Cotugno M; Aneiros-Fernández J; Arias-Santiago S
    Med Clin (Barc); 2013 Aug; 141(4):188. PubMed ID: 23597955
    [No Abstract]   [Full Text] [Related]  

  • 15. Is a functional estrogen receptor always required for progesterone receptor induction in breast cancer?
    Horwitz KB
    J Steroid Biochem; 1981 Dec; 15():209-17. PubMed ID: 7339247
    [No Abstract]   [Full Text] [Related]  

  • 16. Dose-dense and/or metronomic schedules of specific chemotherapies consolidate the chemosensitivity of triple-negative breast cancer: a step toward reversing triple-negative paradox.
    Mehta RS
    J Clin Oncol; 2008 Jul; 26(19):3286-8; author reply 3288. PubMed ID: 18591566
    [No Abstract]   [Full Text] [Related]  

  • 17. Hormone receptors in breast carcinomas.
    Mandal AK
    Indian J Pathol Microbiol; 1995 Jan; 38(1):109-18. PubMed ID: 8919478
    [No Abstract]   [Full Text] [Related]  

  • 18. Ratio of concentrations of estrogen receptors to progesterone receptors (ER/PR) in the cytosol of breast cancers (stratification by forming of groups differing in PR).
    Hochmann J
    Neoplasma; 2007; 54(4):290-6. PubMed ID: 17822318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macromolecular binding of dexamethasone as evidence for the presence of mineralocorticoid receptor in human breast cancer.
    Martin PM; Rolland PH; Raynaud JP
    Cancer Res; 1981 Mar; 41(3):1222-6. PubMed ID: 6780185
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk factors and hormone-receptor status: epidemiology, risk-prediction models and treatment implications for breast cancer.
    Chen WY; Colditz GA
    Nat Clin Pract Oncol; 2007 Jul; 4(7):415-23. PubMed ID: 17597706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.